Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
7502832 | Drug and Alcohol Dependence | 2018 | 26 Pages |
Abstract
Despite the fact that many patients desire to discontinue buprenorphine, a minority had a documented taper. Among those who tapered, more than half did so unsupervised by the clinic and a majority of those who tapered off returned to buprenorphine treatment within two years. As many patients are unable to successfully taper off buprenorphine, the medical community must work to address any barriers to long-term maintenance.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Zoe M. Weinstein, Gabriela Gryczynski, Debbie M. Cheng, Emily Quinn, David Hui, Hyunjoong W. Kim, Colleen Labelle, Jeffrey H. Samet,